Regencell Bioscience Holdings Ltd (RGC)
6.30
+0.20
(+3.28%)
USD |
NASDAQ |
Nov 15, 16:00
6.30
0.00 (0.00%)
After-Hours: 16:34
Regencell Bioscience Holdings Shareholders Equity (Quarterly): 8.219M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 8.219M |
| December 31, 2023 | 10.20M |
| December 31, 2023 | 10.20M |
| June 30, 2023 | 12.03M |
| December 31, 2022 | 14.66M |
| December 31, 2022 | 14.66M |
| June 30, 2022 | 17.07M |
| Date | Value |
|---|---|
| December 31, 2021 | 19.70M |
| December 31, 2021 | 19.70M |
| June 30, 2021 | -3.998M |
| December 31, 2020 | -2.985M |
| December 31, 2020 | -2.985M |
| June 30, 2020 | -2.651M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-3.998M
Minimum
Jun 2021
19.70M
Maximum
Dec 2021
8.755M
Average
10.20M
Median
Dec 2023
Shareholders Equity (Quarterly) Benchmarks
| Sino Biopharmaceutical Ltd | 4.519B |
| HUTCHMED (China) Ltd | 740.08M |
| Pharmaron Beijing Co Ltd | 1.595B |
| Prenetics Global Ltd | 188.24M |
| Uni-Bio Science Group Ltd | 40.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.438M |
| Total Liabilities (Quarterly) | 0.2195M |